Latest News - Transcend Medical

Friday, July 29, 2016 | FDA Approval/Clearance, Alcon, Transcend Medical

FDA Approves CyPass Micro-Stent Minimally Invasive Glaucoma Surgical Device

The FDA has approved Alcon's CyPass Micro-Stent system, the second minimally invasive glaucoma surgical device (MIGS) approved for use in combination with cataract surgery. The device helps to red…

Read the full story

Thursday, February 18, 2016 | Acquisitions/Mergers, Alcon, Transcend Medical

Alcon Acquires MIGS Device Maker Transcend Medical

Alcon is now a player in the growing MIGS market as it entered into an agreement to acquire Transcend Medical, the maker of the CyPass micro-stent to treat mild to moderate glaucoma. Terms of the d…

Read the full story

Friday, October 30, 2015 | Corporate Lawsuits, Glaukos Corporation, Transcend Medical

Glaukos Announces Settlement of Patent Litigation with Transcend Medical

Glaukos announced that it has entered into a settlement agreement with Transcend Medical to resolve all existing patent litigation between the two companies, according to a company news release. Un…

Read the full story

Thursday, October 22, 2015 | Glaucoma, Transcend Medical

Transcend Medical Submits Final Module of FDA Premarket Approval Application for the CyPass Glaucoma Micro-Stent

Transcend Medical announced the submission to the FDA of the final module of the company's premarket approval application for the CyPass Micro-Stent, according to a company news release. The Cy…

Read the full story

Tuesday, September 22, 2015 | Corporate Lawsuits, Glaukos Corporation, Transcend Medical

District Court Rules on Summary Judgment Motions in Glaukos Patent Litigation with Transcend Medical

The United States District Court for the District of Delaware issued rulings on three pending summary judgment motions in Glaukos’s patent lawsuit with Transcend Medical related to Transcend&rsq…

Read the full story

Tuesday, May 05, 2015 | Clinical Trials, Transcend Medical

Transcend Medical Announces Intent to File Premarket Approval Application With FDA for the CyPass Glaucoma Micro-Stent

Transcend Medical announced its intent to file a premarket approval (PMA) application with the FDA for the CyPass Micro-Stent, a novel minimally invasive glaucoma surgical (MIGS) implant, according to…

Read the full story